![24IA2E2E10D5 [24IA2]](http://www.family998.com/static/images/cells-no_picture.jpg)
-
平臺編號：bio-68732
-
國際編號：HB-8049?
-
細(xì)胞信息： 24IA2E2E10D5 [24IA2]
-
規(guī)格：frozen
-
用途：ATCC原裝細(xì)胞
-
服務(wù)費用：
加載中…… - 訂購
-
注意事項：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準(zhǔn)）
24IA2E2E10D5 [24IA2]
ATCC Number：HB-8049?
運輸方式：凍存運輸
生長狀態(tài)：懸浮生長
是否是腫瘤細(xì)胞：0
物種來源：小鼠
細(xì)胞形態(tài)：淋巴樣
免疫類型：IgG
數(shù)量：大量
規(guī)格：10次 Designations: 24IA2E2E10D5 [24IA2]
Depositors: ?Regents of the University of California
Isotype: IgG
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:suspension
Organism: Mus musculus (B cell); Mus musculus (myeloma) deposited as mouse (B cell); mouse (myeloma)
Morphology:lymphoblast
Source: Cell Type: hybridoma: B lymphocyte;
Cellular Products:immunoglobulin; monoclonal antibody; against the p27 protein of Feline Leukemia virus (FeLV)
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Tumorigenic:Yes
Comments:Animals were immunized with purified FeLV p27.
Spleen cells were fused with Sp2/0-Ag14 myeloma cells.
The antibody reacts with the A, B, C, AB and ABC strains of FeLV.
The antibody does not react with RD114 virus or AKR Murine Leukemia virus (MuLV).
Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Subculturing: Medium Renewal: Every 2 to 3 days
Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml.
References: 3873: Lutz H. Hybridomas producing monoclonal antibodies specific for FeLV p27. US Patent 4,713,325 dated Dec 15 1987
運輸方式：凍存運輸
生長狀態(tài)：懸浮生長
是否是腫瘤細(xì)胞：0
物種來源：小鼠
細(xì)胞形態(tài)：淋巴樣
免疫類型：IgG
數(shù)量：大量
規(guī)格：10次 Designations: 24IA2E2E10D5 [24IA2]
Depositors: ?Regents of the University of California
Isotype: IgG
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:suspension
Organism: Mus musculus (B cell); Mus musculus (myeloma) deposited as mouse (B cell); mouse (myeloma)
Morphology:lymphoblast
Source: Cell Type: hybridoma: B lymphocyte;
Cellular Products:immunoglobulin; monoclonal antibody; against the p27 protein of Feline Leukemia virus (FeLV)
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Tumorigenic:Yes
Comments:Animals were immunized with purified FeLV p27.
Spleen cells were fused with Sp2/0-Ag14 myeloma cells.
The antibody reacts with the A, B, C, AB and ABC strains of FeLV.
The antibody does not react with RD114 virus or AKR Murine Leukemia virus (MuLV).
Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Subculturing: Medium Renewal: Every 2 to 3 days
Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml.
References: 3873: Lutz H. Hybridomas producing monoclonal antibodies specific for FeLV p27. US Patent 4,713,325 dated Dec 15 1987
